The synthesis, characterization and luminescent behavior of trivalent Sm, Eu, Dy and Tb complexes of two enantiomeric, octadentate, chiral, 2-hydroxyisophthalamide ligands are reported. These complexes are highly luminescent in solution. Functionalization of the achiral parent ligand with a chiral 1-phenylethylamine substituent on the open face of the complex in close proximity to the metal center yields complexes with strong circularly polarized luminescence (CPL) activity. This appears to be the first example of a system utilizing the same ligand architecture to sensitize four different lanthanide cations and display CPL activity. The luminescence dissymmetry factor, g lum , recorded for the Eu(III) complex is one of the highest values reported, and this is the first time the CPL effect has been demonstrated for a Sm(III) complex with a chiral ligand. The combination of high luminescence intensity with CPL activity should enable new bioanalytical applications of macromolecules in chiral environments.
Introduction
The structure of proteins, nucleic acids and other organic molecules is essential information for an understanding of their function in vivo and hence critical for biochemistry, biology, and molecular biology. The ability to identify different protein conformations is one example of this need, since protein folding is strongly determinant in subsequent function. Recent pertinent examples include the role of a malfolded cellular prion protein in transmissible spongiform encephalopathies 1 (eg. BSE or 'mad cow disease') and the influence of different protein conformations on subsequent spider silk properties. 2 Circularly Polarized Luminescence (CPL) is one of the most sensitive techniques that can be used to determine a protein's conformation in solution, using a luminescent probe that reports on its chiral environment. 3, 4, 23 Ideally, this technique should combine both the general sensitivity of fluorescence with the advantage of high specificity for CPL signals. Due to their long emission lifetimes and sharp emission bands, luminescent complexes, primarily based on Tb(III) and Eu(III), have proven to be very good luminescence probes for CPL applications. As examples, the conformational changes in calcium and iron binding proteins have been investigated using Tb(III) and Eu(III) ions as structural probes, a proof of principle that measurements such as these provide highly specific local information on the chiral environment of the lanthanide metal ion. 5, 6 This information is thus a crucial complement to that obtained through the analogous but much less sensitive chiro-optical absorption technique, circular dichroism (CD), which is often used to determine macromolecular information such as a protein's secondary and tertiary structure. 7, 8 Due to the lanthanides' electronic structure, their complexes have unique optical properties, including luminescence lifetimes that range from micro-to milliseconds, and sharp emission bands whose width at half height (FWHM) rarely exceed 10 nm. [9] [10] [11] This is much narrower than the typically broad fluorescence arising from organic molecule or Cd/Se nanoparticles. 12 As a result of these unique 3 properties, well-designed lanthanide complexes can be used as luminescent probes to analyze biological problems, where a targeted analyte may be present in a matrix that can also contain a large number of other fluorescent molecules (i.e. high background autofluorescence). Similarly, discrimination of the relevant fluorescent signal from that present in biological media (eg. fluorescence from amino acids such as tyrosine or tryptophan) is readily achieved by time gating (a time-resolved measurement). 13 Indeed, the combination of temporal and spectra discrimination properties have led to the development of time resolved fluoro-immunoassays with very high sensitivities, 14 without the need for tedious prior purification of the sample and useful when a very large number of samples must be screened.
Because the lanthanide f-f transitions are Laporte forbidden, 13 the molar absorptivity is very low. The typical strategy to circumvent this is to increase the luminescence excitation by coordinating the luminescent lanthanide ion to a chromophore, which acts as an antenna to effectively transfer light energy to the metal. 15, 16 For example, in biological systems, amino acids such as tryptophan have been utilized for this purpose, although in that case the binding environment is not optimized for the lanthanide cation. 6, 17 In order to form more efficient luminescent lanthanide complexes, chiral complexes have been developed where the coordination geometry around the lanthanide is well defined and controllable , which enables fine tuning of the photophysical properties. 18 Despite these attractive features, there is a limited number of lanthanide based luminescent probes suitable for practical CPL applications in solution. The reason is the weak CPL signal intensity for the complexes described in the literature, due to a combination of limitations imposed by key requirements which must be fulfilled in order to obtain efficient luminescent complexes with detectable CPL signals in solution. First, the limited absorption of lanthanide cations must be overcome by coordinating a ligand that is able to harvest significant amounts of UV or visible light and then efficiently transfer this electronic energy to the lanthanide metal ion. Second, since the excited states of the lanthanide cations can be easily deactivated through non-radiative interaction with their chemical environment (coupling to vibrational modes of solvent molecules or of the ligand), the lanthanide must be protected from this Highly Luminescent Lanthanide Complexes with CPL Activity 4 quenching environment when bound to the ligand. This implies that the ligand must fulfill the high coordination number requirement of the lanthanide cation by providing an adequate number of donor atoms (typically between 8 and 12 in solution). Third, the ensuing complex must have sufficient thermodynamic stability and/or kinetic inertness at the appropriate concentration to interact with, and report on, the macromolecule of interest, since dissociation would lead to loss of the antenna effect and a subsequent decrease in luminescence. Fourth, to observe an unambiguous CPL signal it is preferable that only a single enantiomer of the chiral complex be present in solution, or more specifically, the existence of only one of these enantiomers must match the time scale of the experiment (microseconds to milliseconds depending on the nature of the lanthanide cation). Hence, any type of exchange between the complex and the environment in the luminescence time-scale should be avoided. Ideally, a rigid, non-fluxional complex, with a saturated coordination sphere should best satisfy this latter condition.
We have reported the properties of a new family of lanthanide complexes formed with ligands incorporating 2-hydroxyisophthalamide as the chelating unit. 19 Upon coordination, these complexes demonstrate several superior luminescence properties, including highly efficient transfer of electronic excitation from the ligand to metal center and sufficient protection of the lanthanide metal ion against non-radiative deactivation from the environment (eg. solvent molecules). Indeed, the quantum yield of the Tb(III) complex in H 2 O, 61 %, is the highest value yet reported for a luminescent metal complex in aqueous solution. In addition, these newly developed ligands allow the sensitization of four different trivalent lanthanides emitting in the visible (Sm, Eu, Tb and Dy) with the same ligand. Herein, we have extended the superior luminescence properties of these complexes to CPL activity by the addition of a chiral substituent to the open face of an octadentate, tetrapodal ligand framework, utilizing the 2-hydroxyisophthalamide chelating unit as the sensitizer. This strategy results in the formation of enantiomerically pure complexes with strong circular dichroism (CD) activity. Significantly, these complexes are also strongly luminescent, emitting in the visible region, and display strong CPL activity.
As a result of their brightness and improved signal to noise ratio, these complexes present new possibilities for increased sensitivity of assays based on CPL measurements. While the Tb(III) complex reported here is the most fluorescent, the strongest CPL effect has been observed for the Eu(III) complex, with one of the highest ΔI values reported to date. In addition, the Dy(III) and Sm(III) complexes are also luminescent and have significant CPL activity, a unique feature which enables us to have four different luminescent probes that can be easily discriminated from each other; since the sharp emission bands do not appreciably overlap multiplex detection is possible.
Experimental
Synthesis N,N,N',N'-tetrakis-(2-aminoethyl)-ethane-1,2-diamine (H22) was prepared by a literature procedure. 20 Unless stated otherwise, all other reagents were purchased from commercial suppliers and used as supplied. 
2-Methoxy-bis(2-mercaptothiazolide)-isophthalic acid

Me 4 R(+)BnMeH22IAM
Me 4 (H22IAM)(2-mercaptothiazolide) 4 ArH and NH). 13 
Me 4 S(-)BnMeH22IAM
This compound was prepared by the same procedure as for Me 4 R(+)BnMeH22IAM, except S(−)αmethylbenzylamine was used instead of the R(+)α-methylbenzylamine enantiomer. Separation and purification were performed as described above. The 1 H and 13 C NMR are essentially identical to that of
H 4 R(+)BnMeH22IAM
Me 4 R(+)BnMeH22IAM was dissolved in 40 mL of dry, degassed CH 2 Cl 2 and BBr 3 was introduced to the solution under a nitrogen atmosphere via syringe. The resulting yellow slurry was stirred for 48 h.
The slurry was slowly quenched with MeOH, after which the reaction mixture was diluted with 100 mL of water. The mixture was boiled for 5 h and then the hot water was decanted away from an oily residue remaining in the flask. The residue was dissolved in CH 2 
This compound was prepared using the same deprotection procedure as for Me 4 R(+)BnMeH22IAM. 
Physical Methods
UV-Visible absorption spectra were recorded on Perkin-Elmer Lambda 9 and Lambda 19 double beam absorption spectrometers using quartz cells of 0.10 and 1.00 cm path lengths. Circular dichroism spectra were recorded on Jasco J-810 and Jasco J-710 instruments. Emission spectra were acquired on a HORIBA Jobin Yvon IBH FluoroLog-3 spectrofluorimeter, equipped with 3 slit double grating excitation & emission monochromators with dispersions of 2.1 nm/mm (1200 grooves/mm). Spectra were reference corrected for both the excitation light source variation (lamp and grating) and the emission spectral response (detector and grating). Quantum yields were determined by the optically dilute method 21 using the following equation:
Here A is the absorbance at the excitation wavelength (λ), I is the intensity of the excitation light at the same wavelength, n is the refractive index and D is the integrated luminescence intensity. The subscripts 'x' and 'r' refer to the sample and reference respectively. In this case, quinine sulfate in 1.0 N sulfuric acid was used as the reference (Q r = 0.54). 22 Luminescence lifetimes were determined on two different instruments. The first was a HORIBA Jobin In both cases, each trace contained at least 10,000 points and the reported lifetime values result from at least three independent measurements. Typical sample concentrations for both absorption and fluorescence measurements were ca. 10 -4 -10 -6 M and 1.0 cm cells in quartz suprasil or equivalent were used for all measurements.
Circularly polarized luminescence and total luminescence spectra were recorded on an instrument by literature procedures, 23 
Results
Ligand Design and Synthesis
Octadentate ligands formed with four 2-hydroxyisophthalamide chelating groups tethered by a flexible alkylamino backbone such as H22IAM have proven to be efficient ligands for the coordination of luminescent lanthanide cations. 19 The methyl group of the amide group on the open face of the ligand has been replaced, yielding the two homochiral enantiomeric R(+) or S(−) forms of a chiral benzyl methyl substituent. This then gives an enantiomerically pure chiral form of the parent complex for CPL applications. This design strategy minimizes the distance between the stereogenic centers and the lanthanide cation, and should maximize the chirality of the excited state environment for the complex and subsequent CPL effects.
UV-Visible Absorption and Circular Dichroism
The absorption spectra of the ligands are dominated by an intense transition with an apparent maximum at ca. 316 nm which upon complexation is red shifted by ca. 30 nm, with a new absorption band at ca. 350 nm. This change is essentially invariant for each of the lanthanide complexes (Sm(III), Eu(III), Tb(III) and Dy(III)) and is attributed to deprotonation and metal coordination by the phenols. 24 A similar effect has been observed 25 with other 2-hydroxyisophthalic acid derivatives upon complexation with beryllium and the absorption bands of the complexes reported here are very similar to those reported previously 19 for the parent octadentate 2-hydroxyisophthalamide ligand (H22IAM).
Circular dichroism (CD) measurements indicate that both the free ligands and their complexes are chiral in methanol solution. In particular, the ligand does not appear to have epimerized when placed in solution or when the reaction mixture was heated in the presence of base during the synthesis of the complexes. 26 Furthermore, the two enantiomeric R(+) and S(−) forms of the complexes are mirror images in their observed CD spectra, as illustrated in Figure 1 for the Tb(III) complexes. For practical applications, the low energy of this excitation wavelength has the advantage of being essentially harmless toward biological material, whereas most of the lanthanide complexes described in the literature to date have excitation bands located at significant higher energy, typically between 300 and 330 nm. 27, 28 
Emission Spectra and Luminescence Lifetimes
Upon UV irradiation, solutions of the free ligands (ca. 10 -4 M) emit a strong blue luminescence (apparent λ max = ca. 410 nm) that can be easily detected with the naked eye. However, upon complexation this emission is replaced by the typical luminescence color arising from the corresponding lanthanide cation (red for Eu(III), green for Tb(III), yellow/grey for Dy(III) and pink-purple for Sm(III)). These colors can also be easily visualized using a standard laboratory UV lamp (λ ex ≈ 365 nm, As shown in Figure 3 , inspection of the emission spectra for the R(+) complexes in solution reveals the typically sharp luminescence bands, characteristic of the different lanthanide cations. Furthermore, it can be seen that each lanthanide complex possesses at least one transition that does not significantly overlap with transitions of the other complexes. Hence, as was reported 19 for the parent octadentate H22IAM complexes, the chiral derivative reported here also allow for the sensitization of four different lanthanide complexes, in this case each active for CPL.
Luminescence efficiency has been assessed by quantum yield determinations upon ligand excitation for each of the differing complexes, with results as summarized for the R(+) form in Table 1 . These values are quite similar to those previously reported 19 for the parent lanthanide complexes formed with the 2-hydroxyisophthalamide moieties as the chelating group, in particular for Tb(III), indicating the chiral substituent has only a slight effect on the photophysical properties of the ensuing complex.
However, as evident from the emission spectra (Figure 3 ), a significant amount of ligand emission centered at ca. 410 nm is observed for the Eu, Sm and Dy chiral derivatives, indicating the intramolecular ligand to lanthanide energy transfer is incomplete, in contrast to the parent H22IAM derivatives and the Tb(III) complex reported here. This observation may also account for the slightly diminished quantum yield values observed here; although these complexes can still be considered as the brightest complexes with CPL activity. These intense signals are a significant advantage for practical bio-analytical applications, as it will allow for improved sensitivity to be obtained by improving the signal to noise ratio.
In addition to steady state measurements, the luminescence lifetimes of the different lanthanide complexes were determined. The resultant mono-exponential decays for the R(+) form as summarized in Table 1 . As expected, the values obtained for the S(−) enantiomeric form were identical within the experimental error. We also note the luminescence lifetimes were strongly influenced by the water content of the MeOH solvent, and this effect was particularly evident in the case of Eu(III), which is known to be more sensitive to the presence of OH oscillators. 13 Nonetheless, the relatively long luminescence lifetimes are an indication that the octadentate ligand scaffold provides a significant level of protection from non-radiative deactivation of the lanthanide cations by the solvent molecules. For the R(+) enantiomeric form of the Tb(III) and Eu(III) complexes, the luminescence lifetime measurements were also performed in MeOD, which allowed an estimate of the number of bound solvent molecules to be made using the empirical Horrock's relationship; 29
where k D and k H refer to the radiative decay rates (1/τ) observed in the deuturated and non-deuterated solvent respectively, and A is an empirical constant evaluated as 8.4 ms -1 and 2.1 ms -1 for Tb(III) and
Eu(III). The resulting n parameter was evaluated to be 1.0 (± 0.5) and 1.2 (± 0.5) respectively, suggesting a single bound solvent molecule, which would also account for the diminished quantum yields, in particular for the Eu(III) complexes, when compared to the parent H22IAM complex.
However, these values may also be an overestimate, since, as discussed elsewhere by Parker et. al., 30 Figure 3 , these wavelengths are particularly well suited for CPL measurements since these transitions satisfy the magnetic dipole selection rule, ΔJ = 0, ±1 (except 0 ↔ 0), where it is predicted the CPL signal should be large. 31 As shown in Figure 4 , for Eu(III) and Tb(III) respectively, and in Figure 5 where I L and I R refer to the intensity of left and right circularly polarized light respectively, is quite different for the four metal centres, with results as summarized in Table 2 .
In addition to the magnitude of the CPL signal, the line shape of the observed spectra also differ significantly for the four lanthanide complexes, as each CPL spectrum displays several peaks corresponding to crystal-field splitting of the electronic level. For Eu(III), the splitting of the 7 F J levels is much less than for the analogous Sm(III), Dy(III), or Tb(III) complexes, and simpler spectra are obtained which are more amenable to structural interpretation. In particular, it is of interest to note that at least four distinguishable peaks are seen in the Eu(III) 5 D 0 → 7 F 1 transition (Figure 4) , whereas, under tetragonal or lower symmetries, a maximum of three crystal field bands (2J + 1) should be observed. As a consequence, it can be concluded that there exists more than one conformation of this complex present in MeOH solution. For comparison, the CPL spectrum of the [EuR(+)BnMeH22IAM]complex was also measured in DMF solution (Fig. S1, Supp Info) , but yielded essentially identical spectra to those obtained in MeOH. The significant CPL activity resulting from the Sm(III) and Dy(III) compounds reported here is promising for further CPL studies and it appears this is the first reported observation of CPL activity from a Sm(III) complex formed with a chiral ligand. The addition of these two luminescent probes is an exciting prospect for multiplex measurements based on the sensitivity of these lanthanide complexes.
While most of the CPL reports in the literature involving Dy(III) and Sm(III) ions refer to the measure of racemic complexes with achiral ligands, there is one report of CPL for a chiral DOTA-based ligand Dy(III) complex with a larger CPL dissymmetry factor (g lum = -0.41 at 667 nm) than reported here. 32 However, for Eu(III), the reported g lum values reported herein are some of the highest ever observed, and the CPL signal from the Tb(III) complexes, while not as large, are also easily measurable. The stronger signal from the Eu(III) complex as compared to the Tb(III) compound is in accordance with previously observed behavior from other complexes with approximately C 4 symmetry. 23
Conclusions
We report chiral, octadentate, 2-hydroxyisophthalamide ligands whose lanthanide complexes have good luminescence properties in solution and strong CPL activity. This is apparently the first system where the same ligand architecture is able to sensitize four different luminescent lanthanide cations (Sm(III), Eu(III), Tb(III) and Dy(III)), each of which with a characteristic emission band in the visible region and each of which is also active for CPL measurements (suitable for chiral multiplex conditions). This is also the first report of a Sm(III) complex formed with a chiral ligand that has CPL activity.
While the Eu(III) complex displays one the highest CPL intensities described in the literature, its overall quantum yield is relatively modest. In contrast, the Tb(III) complex, which has a much greater quantum yield, displays a weaker CPL effect. Generally, these two effects will self-compensate, allowing the complexes to have a good compromise between luminescence intensity and CPL activity.
The complexes described here have luminescent lifetimes ranging from the microsecond to millisecond time scale. This feature facilitates the appropriate selection of a complex with a luminescence lifetime corresponding to the type of experiment or assay to be performed, which will in itself be dependent on the kinetics of the biological event taking place in solution.
Lastly, it is pertinent to note the existence of several coordination environments about the central 
